J1823 HCPCS code: Injection, inebilizumab-cdon, 1 mg
J1823 is the HCPCS Level II code for injection, inebilizumab-cdon, 1 mg. In 2024 Medicare paid an average of $363.15 per service for J1823 across 54,956 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 89% from 2022 to 2024 (29,108 to 54,956 services). In 2024, about 114 clinicians billed Medicare for J1823 for 98 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2021-01-01 |
| Last action effective | 2021-01-01 |
Who bills J1823 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 114 |
| Medicare beneficiaries | 98 |
| States with claims | 2 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1823, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 29,108 | 53 | $446.60 | $356.59 |
| 2023 | 43,527 | 80 | $420.12 | $334.68 |
| 2024 | 54,956 | 98 | $455.84 | $363.15 |
States with the most J1823 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 16,950 | $365.04 |
| Florida | 5,300 | $345.42 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J1823
- 2021-01-01: J1823 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1823?
J1823 is the HCPCS Level II code for injection, inebilizumab-cdon, 1 mg. Short descriptor: "Inj. inebilizumab-cdon, 1 mg".
How much does Medicare pay for J1823?
In 2024, the average Medicare payment was $363.15 per service (average allowed $455.84).
Does Medicare cover J1823?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1823 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J18 codes
- J1800 — Injection, propranolol hcl, up to 1 mg
- J1805 — Injection, esmolol hydrochloride, 10 mg
- J1806 — Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807 — Injection, ethacrynate sodium, 1 mg
- J1808 — Injection, folic acid, 0.1 mg
- J1809 — Injection, fosdenopterin, 0.1 mg
- J1810 — Injection, droperidol and fentanyl citrate, up to 2 ml ampule
- J1811 — Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812 — Insulin (fiasp), per 5 units
- J1813 — Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814 — Insulin (lyumjev), per 5 units
- J1815 — Injection, insulin, per 5 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1823
- Watch J1823 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1823
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.